- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor Which conditions qualify? The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis in America Medical Cannabis Access for Pain Treatment
- Join Join
Policy Recommendations New Jersey
2019-2020 Improvements and Recommendations for New Jersey
New Jersey lawmakers spent much of the 2019 legislative session negotiating details of legislation to create a new adult-use commercial cannabis marketplace, though political disputes sidelined those efforts until 2020. However Governor Murphy was successful in ushering in sweeping reforms to the state's medical program under the Jake Honig Compassionate Use Medical Cannabis Act. The new law increases the monthly limit to 3 oz over an 18-month period, and exempts terminally ill patients from the monthly limit. It also increases from 90 days to one year the amount of cannabis that patients can secure in an effort to reduce the number of visits required by patients to obtain a sufficient supply of medicine and decrease costs to patients.
Additional features of the new law include permission of adult patients to consume edibles (previously only available to minors), a 3-year phase out of government taxes imposed on medical cannabis, and expansion of health practitioner classifications authorized to recommend cannabis beyond physicians to include physician assistants and advanced practice nurses. The measure includes other cost-saving and flexibility provisions, such as allowing patients to have up to two caregivers, authorizing delivery, and increasing the number of licensed dispensaries from six to twelve. Additional provisions cover employment protections for registered patients, storefronts to list product pricing information online consistent with in-store pricing, and reciprocity.
In the November 2020 elections, New Jersey voters chose to legalize cannabis for all adults across the state.
In addition, NJ organized expanded access features for patients under COVID, permitting pre-ordering, curbside pickup, delivery, and telehealth for physician evaluations. For 2021 ASA encourages NJ to expand civil discrimination protections in the areas of housing, parental rights and organ transplants.